Rady Children’s Institute for Genomic Medicine is excited to announce that the current version of our rWGS/urWGS test is now validated to include identification of repeat expansions in the PHOX2B gene, associated with Congenital Central Hypoventilation Syndrome (CCHS), and in the DMPK gene, associated with Myotonic Dystrophy Type 1 (DM1).
For the first time in more than 80 years, San Diego County is expecting a tropical storm to arrive. RCIGM is prepared with back up devices and resources to support any possible outages and downtimes to the best of our ability.
Here at Rady Children's Institute for Genomic Medicine®, we're known for our rapid turnaround on tests. Our aim with this blog is to provide you with quick, speedy updates on things relevant to our core work: clinical genomic services, lab tests, rWGS reimbursement, and more. Stay tuned for more.
San Diego – February 18, 2021 – Rady Children’s Institute for Genomic Medicine (RCIGM) is now licensed by New York State to perform clinical molecular testing making the Institute one of the few laboratories nationwide approved to perform whole exome and whole genome sequencing (WGS) on samples sent from all 50 states and the District of Columbia.